Study Shows More Hospital Deaths and Invasive Care for Dying Cancer Patients Who Receive Chemotherapy
A study by researchers at Dana-Farber Cancer Institute and Weill Cornell Medical College shows terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more likely to undergo...
2/28/2014 11:00 AM EST
Nivolumab, a drug that unleashes the immune system to attack cancer, has shown to produce lasting remissions and hold the disease in check – for more than two years, in some cases – in many patients with advanced melanoma, according to a new...
3/3/2014 2:45 PM EST
A normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme in acute myelogenous leukemia, to promote cancer growth & resistance to treatment with FLT3-blocking drugs. In mouse model, treatment with a drug combination to inhibit...
2/10/2014 2:00 PM EST
Long-Term Survival Among Patients with Most Common Childhood Brain Tumor Is High; Lower if Treatment Included Radiation
Study of long-term survival of children with most common pediatric brain tumor finds almost 90 percent are alive 20 years later and few died from the tumor as adults. However, children treated with radiation had significantly lower long-term...
2/3/2014 3:40 PM EST
Dana-Farber researchers have found that a combination of two already-in-use drugs may have an effect on stopping the growth of the most common genetic subtype of lung cancer setting the stage for clinical trials.
1/30/2014 4:00 PM EST
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.
1/23/2014 5:00 PM EST
Scientists have identified a mutated gene that causes a type of tenacious, benign brain tumor that can have devastating lifelong effects. Currently, the tumor can only be treated with challenging repeated surgeries and radiation.
1/9/2014 5:00 PM EST
In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL). The...
1/9/2014 2:00 PM EST
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
3/5/2014 5:00 PM EST
11/11/2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
9/17/2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
6/7/2013 12:00 PM EDT
5/24/2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
5/17/2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
10/23/2009 1:00 PM EDT